These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23766292)

  • 1. Whole-body scanning PCR; a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides.
    Boos JA; Kirk DW; Piccolotto ML; Zuercher W; Gfeller S; Neuner P; Dattler A; Wishart WL; Von Arx F; Beverly M; Christensen J; Litherland K; van de Kerkhof E; Swart PJ; Faller T; Beyerbach A; Morrissey D; Hunziker J; Beuvink I
    Nucleic Acids Res; 2013 Aug; 41(15):e145. PubMed ID: 23766292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Body Scanning PCR, a Tool for the Visualization of the In Vivo Biodistribution Pattern of Endogenous and Exogenous Oligonucleotides in Rodents.
    Boos JA; Beuvink I
    Methods Mol Biol; 2016; 1372():99-111. PubMed ID: 26530918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay.
    Godinho BMDC; Gilbert JW; Haraszti RA; Coles AH; Biscans A; Roux L; Nikan M; Echeverria D; Hassler M; Khvorova A
    Nucleic Acid Ther; 2017 Dec; 27(6):323-334. PubMed ID: 29022758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse Models.
    Tu MJ; Yi CM; Traber GM; Yu AM
    Methods Mol Biol; 2022; 2521():191-206. PubMed ID: 35732999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated parallel synthesis of 5'-triphosphate oligonucleotides and preparation of chemically modified 5'-triphosphate small interfering RNA.
    Zlatev I; Lackey JG; Zhang L; Dell A; McRae K; Shaikh S; Duncan RG; Rajeev KG; Manoharan M
    Bioorg Med Chem; 2013 Feb; 21(3):722-32. PubMed ID: 23260577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of phosphodiester and phosphorothioate siRNA.
    Braasch DA; Paroo Z; Constantinescu A; Ren G; Oz OK; Mason RP; Corey DR
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1139-43. PubMed ID: 14980652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification and characterization of non-coding and coding RNAs and their modified nucleosides by mass spectrometry.
    Gaston KW; Limbach PA
    RNA Biol; 2014; 11(12):1568-85. PubMed ID: 25616408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular RNA-tracking methods.
    George L; Indig FE; Abdelmohsen K; Gorospe M
    Open Biol; 2018 Oct; 8(10):. PubMed ID: 30282659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs).
    Viel T; Boisgard R; Kuhnast B; Jego B; Siquier-Pernet K; Hinnen F; Dollé F; Tavitian B
    Oligonucleotides; 2008 Sep; 18(3):201-12. PubMed ID: 18729822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybridisation of [76Br]-labelled antisense oligonucleotides to Chromogranin A mRNA verified by RT-PCR.
    Wu F; Lendvai G; Yngve U; Eriksson B; Långström B; Bergström M
    Nucl Med Biol; 2004 Nov; 31(8):1073-8. PubMed ID: 15607489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
    Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
    Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding oligonucleotides: the belle of the ball in gene therapy.
    Shum KT; Rossi JJ
    Adv Genet; 2015; 89():153-177. PubMed ID: 25620011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo.
    Biscans A; Coles A; Echeverria D; Khvorova A
    J Control Release; 2019 May; 302():116-125. PubMed ID: 30940496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-Triggered RNA Annealing by an RNA Chaperone.
    Panja S; Paul R; Greenberg MM; Woodson SA
    Angew Chem Int Ed Engl; 2015 Jun; 54(25):7281-4. PubMed ID: 25959666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene function in somatic mammalian cells using small interfering RNAs.
    Elbashir SM; Harborth J; Weber K; Tuschl T
    Methods; 2002 Feb; 26(2):199-213. PubMed ID: 12054897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic oligonucleotides with polyethylene glycol modifications.
    Winkler J
    Future Med Chem; 2015; 7(13):1721-31. PubMed ID: 26465713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides.
    Senn C; Hangartner C; Moes S; Guerini D; Hofbauer KG
    Eur J Pharmacol; 2005 Oct; 522(1-3):30-7. PubMed ID: 16213482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Mol Cancer Ther; 2007 Mar; 6(3):833-43. PubMed ID: 17363479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA.
    Allerson CR; Sioufi N; Jarres R; Prakash TP; Naik N; Berdeja A; Wanders L; Griffey RH; Swayze EE; Bhat B
    J Med Chem; 2005 Feb; 48(4):901-4. PubMed ID: 15715458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.